This study was performed to evaluate the characteristics of penile erection during midazolaminduced sedation after nocturnal sleep deprivation (NSD) and to determine the effect of NSD on erectile episodes in healthy, sexually functional young men. This procedure might possibly prove to be a brief office-based method of assessing whether erectile dsyfunction is psychogenic or biogenic. Nineteen volunteers between the ages of 20 and 29 years participated in this study. We measured the morning penile erection after midazolam (3-5 mg) administration intravenously and all subjects completed 42 tests. Of 42 test, 28 tests revealed erectile episodes, wereas no erectile episodes were observed in 14 tests. Nocturnal sleep deprivation rate was significantly higher in tests with erectile episodes than in tests without erectile episode (P ¼ 0.030). Test order or duration of test was not different between two test results. Number of erectile episodes (r ¼ 0.374, P ¼ 0.015), tip radial rigidity (r ¼ 0.412, P ¼ 0.007), base radial rigidity (r ¼ 0.366, P ¼ 0.017) and tip tumescence (r ¼ 0.447, P ¼ 0.003) correlated with the degree of NSD. When we determined whether NSD was discriminative with regard to erectile episodes, the area under the receiver operating characteristic curve was calculated at 0.705 (95% confidence interval, 0.527-0.883; P ¼ 0.032) for the possibility of erectile episodes. Nocturnal sleep deprivation might recover the inhibited rapid eye movement sleep during midazolam-induced sedation. Our findings suggest that erection monitoring during midazolam-induced sedation after NSD may be convenient. However, validation of midazolaminduced morning penile tumescence monitoring with a large population is mandatory.
Introduction
Sleep-related penile erections occur in all healthy, potent men in close temporal association with rapid eye movement sleep. Nocturnal penile tumescence monitoring provides a physiologic, objective, diagnostically useful technique for evaluating erectile capacity because sleep-related penile erections are naturally occurring, physiologically normal, occur several times on any given night, and are stable across time. Although clinical sleep-related penile erection testing is less commonly applied today with the advent of minimally invasive medical therapies for erectile dysfunction, as an objective measure of erectile function, sleep-related penile erection recording for research provides a precise technique for examining the mechanisms of erection and is still conducted to resolve legal disputes. However, in the standard sleep-related penile erection evaluation, patients sleep in a hospital setting for two or three nights, reporting to the facility 1-2 h before their normal bedtime. Thus, practical drawbacks of sleep-related penile erection monitoring include the cost and inconvenience. 1 To date, a wide assortment of alternative techniques emerged, [2] [3] [4] but these methods have met with only limited success. 5 Midazolam has been most widely used as a sedative premedication because it has lots of advantages, such as a short half-life, a faster onset of sedation and an excellent sedative hyponotic effect without any particular side effects, such as vasculitis. Several classes of drugs can adversely affect erectile function and sleep-related penile erections. Some drugs act directly on sleep-related penile erections while others act indirectly by altering rapid eye movement sleep. Antiandrogens decrease sleep-related penile erections without necessarily affecting rapid eye movement sleep. The betablocker propanolol can decrease sleep-related penile erections in some men. 6 Tricyclic antidepressants, monoamine oxidase inhibitors, and selective serotonin reuptake inhibitors all potentially suppress rapid eye movement sleep and are known to adversely affect sexual function in some individuals. Since rapid eye movement sleep may be inhibited during midazolam-induced sedation, 7, 8 midazolam act directly or indirectly on sleep-related penile erection.
Electroencephalography patterns of the morning after nocturnal sleep deprivation (NSD) resembled sleep stages from the second half of the night, with rapid eye movement sleep dominating. 9 Nocturnal sleep deprivation resumed their previously interrupted rapid eye movement cycles at the next sleep onset. Thus, it may be hypothesized that NSD may recover the inhibited rapid eye movement sleep during midazolam-induced sedation. This study was performed to evaluate the characteristics of penile erection during midazolam-induced sedation after NSD in healthy, sexually functional young men and to identify the effect of NSD on penile erections during midazolam-induced sedation in this population. The purpose of this study was to assess the possibility of the erection monitoring during midazolam-induced sedation as an alternative to sleep-related penile erection testing.
Patients and methods

Patients
From March to August of 2005, 19 sexually functional and active young adult men between the ages of 20 and 29 years (mean: 25.970.7 years) participated in this study. A disorder-free medical and sexual history and normal erectile functions were the only inclusion criteria. Subjects who had severe cardiovascular disease, pulmonary disease, a chronic alcohol history or drug abuse were not included in the study. We also excluded subjects taking medications such as erythromycin, verapamil, diltiazem, itraconazole and ketoconazole, which are capable of drug interactions with the benzodiazepine class of midazolam specifically. Each subjects provided informed consent and studies were approved by institutional review boards at our medical center.
Study design
We measured the subjects' sleep-related penile erection monitoring over a consecutive three nights using Rigiscan-Plust (DacoMed, Minneapolis, MN, USA). In addition, all night continuous polysomnograms were recorded according to standard practice. On each night, technicians attached sensors to the subjects to monitor penile base and tip circumference changes. We recorded data from five electroencephalography channels, two electrooculography channels, one electromyography, three electrodermal activity channels (EDA), one electrocardiography channel, and one respiratory airflow channel. The EDA channels (medical phalanx of middle finger of left hand, medial phalanx of middle finger of right hand, penis) monitored skin resistance responses.
The morning penile erection monitoring was performed up to third session until it showed erectile episodes. Medications such as nicotine, alcohol, caffeinated beverages were avoided in all volunteers for at least 12 h before to the morning penile erection monitoring in order to maximize the likelihood that they would able to sleep. To resume rapid eye movement sleep from the previous night's interrupted sleep, deprivation of their normal night's sleep before the morning penile erection monitoring were recommended to all subjects. Morning penile tumescence recording and polysomnographic recording were started between 0700 and 1000 hours and recording duration was 1-3 h. Subjects slept in private, electrically shielded, sound-attenuated, temperature-controlled bedrooms.
Midazolam was administered intravenously to the subjects at doses of 3-5 mg. The initial intravenous dose was 1 mg (no more than 0.03 mg/kg) given slowly over at least 2 min, titrating to the desired level of sedation. An intravenous dose of 0.02-0.03 mg/kg was repeated at 2-min intervals while continually monitoring for the appropriate level of sedation. A total intravenous dose of more than 5 mg was not necessary for all examinations. After the administration of midazolam, the presence of complications or side effects including apnea, oxygen desaturation, autonomic movement, chest pain, arrythmia, injection in situ pain and phlebitis were examined. The criterion of discharge was that subjects have fully recovered orientation in time and space with vital signs within the normal range. In this study, we did not use flumazenil, the antidote for midazolam for the rapid recovery of consciousness and orientation.
Statistical analysis
The survey responses were coded and analyzed using descriptive statistics, which are reported as the median with 25th to 75th percentiles (quantitative variables) or as the number and percentage Sedation-induced erections YS Song et al (qualitative variables). The statistical analysis was carried out using Mann-Whitney U-test for continuous data and w 2 test for categorical data. Spearman's correlation coefficients were determined to evaluate the associations with the degree of sleep deprivation and the data regarding erectile episodes. We attempted to determine whether or not sleep deprivation was discriminative for erectile episodes during midazolam-induced sedation, using the area under the receiver operating characteristic (ROC) curve. The area under this curve is generally considered to be an appropriate parameter for the summarization of the overall discriminative or diagnostic value of a model, and can range from 0.5 (flipping a coin, a useless model) to 1.0 (perfect discrimination). 10 The closer the area under the ROC curve approached to 100% (i.e. the more the ROC curve approached the upper left corner), the greater the predictive power of the model is considered to be. A value exceeding 0.7 is interpreted as reasonable, and a value in excess of 0.8 is considered to be good. 11 A 5% level of significance was used throughout, and all statistical tests were two sided. The statistical analyses were performed using a commercially available program, SPSS 10.0 (SPSS Inc., Chicago, IL, USA).
Results
Full erection was observed in sleep-related penile erection monitoring in nocturnal penile tumescence monitoring. All 19 subjects completed 42 tests for erectile episodes during midazolam-induced sedation and all sessions were less than 3 h in duration. Aforementioned side effects of midazolam were not detected in the present study. Of 19 subjects, erectile episodes were noted in 18 subjects. Of 42 tests, 28 tests revealed erectile episodes, while no erectile episodes were observed in 14 tests. The median number of sessions needed to observe erectile episodes was 1 (range 1-3). In test with erectile episodes, rapid eye movement sleep was observed and erections with good quality were present during midazolam-induced sedation. The results are shown in Table 1 . Table 2 shows the characteristics according to erectile episodes during midazolam-induced sedation. Sleep deprivation rate was significantly higher in tests with erectile episodes than in tests without erectile episode (66.0 versus 50.2%, P ¼ 0.030). Test order or duration of test was not different between two test results.
Spearman's correlation coefficients were performed to evaluate the associations between the sleep deprivation and erection. Among parameters, number of erectile episodes (r ¼ 0.374, P ¼ 0.015), tip radial rigidity (r ¼ 0.412, P ¼ 0.007), base radial rigidity (r ¼ 0.366, P ¼ 0.017) and tip tumescence (r ¼ 0.447, P ¼ 0.003) correlated with the degree of sleep deprivation. However, duration of erection and base tumescence did not correlate with the degree of sleep deprivation. Table 3 contains the correlation coefficients between the sleep deprivation and the data of erectile episodes.
When we determined whether sleep deprivation was discriminative with regard to erectile episodes, 
Discussion
The comparative study of penile behavior during sleep in different species might be particularly rewarding for the understanding of the functional organization of the brain in that physiologic state.
Although the neuronal control of rapid eye movement sleep-related penile erections remains unknown, it has been suggested that the areas in the forebrain may play an important role in rapid eye movement sleep-related penile erections. 12 In the forebrain, the lateral preoptic area has been implicated in sleep-related penile erections. 13 The sleep-related penile erection characteristics of patients even in vegetative state are similar to those of normal individuals. 14 Although reports on sleeprelated penile erections in mammalian species different from humans are extremely scanty, the occurrence of sleep-related penile erections during rapid eye movement sleep has also been reported in rats. 15 However, paradoxical sleep erectile events may be not a universal phenomenon of mammalian physiology. Although microinjection of carbachol, a cholinergic agonist, into certain region of the pontine tegmentum in rats induced rapid eye movement sleep-like state, 16 carbachol-induced rapid eye movement sleep was not accompanied by penile erections in rats. 17 In addition, penile erections were not observed during paradoxical sleep in the armadillo Chaetophractus villosus.
18
Midazolam has a high affinity for the benzodiazepine receptor in the central nervous system, with in vitro data demonstrating approximately twice the affinity of diazepam. 19, 20 The amino-acid neurotransmitter gamma-aminobutyric acid (GABA) must be present for the benzodiazepine to elicit a response 21 and benzodiazepines enhance the inhibitory action of the GABA. 22 The actions of benzodiazepines do not involve the synthesis, release, or altered metabolism of GABA but rather potentiate the inhibitory actions of GABA by augmenting the flow of chloride ions through ion channels. The increase flux of chloride ions into the cell decreases the ability of the cell to initiate an action potential. In contrast to full night sleep-related penile erection studies, where a first night effect has been observed, we found that volunteers fell asleep quickly and slept well in this study and that NSD might recover the inhibited rapid eye movement sleep during midazolam-induced sedation. Furthermore, the short period of morning penile tumescence recording faithfully reflects the changes noted during the 8 or more hours of sleep-related penile erection tracings. Comparison of tracings of penile activity at night and during the daytime periods shows a remarkable internal consistency. It is reported that electroencephalographic patterns of the nap in the early morning resembled sleep stages from the second half of the night, with rapid eye movement sleep dominating. Morning nap resumed their previously interrupted rapid eye movement cycles at the next sleep onset, with rapid eye movement onset frequently occurring within 10 min of nap onset. 24 Nocturnal sleep deprivation might resume their previously interrupted rapid eye movement cycles at the next sleep onset.
As diurnal penile tumescence may be a summary reflection of sleep-related penile erections, tumescence monitoring during naps may be useful as an inexpensive and convenient screening approach in the assessment of male erectile dysfunction. [25] [26] [27] For the clinician, a major attraction of daytime penile tumescence monitoring is the opportunity to evaluate sequentially several patients at the same time facility and at regular intervals during office hours. Our findings suggest that erection monitoring during midazolam-induced sedation after NSD may be convenient inasmuch as it requires less time of both the practitioner and the patients, and it can be conducted in an outpatient setting. However, In the present study, the sample size was small, participants in this study were young, sexually healthy men, and no consensus of the criteria about normal morning penile tumescence findings was made. Thus, it is possible that older or dysfunctional men might respond differently. To complete the process of validation, large groups of normal subjects and impotent patients with a defined etiology must be studies to establish norms for morning penile tumescence recording.
